Protalix BioTherapeutics, Inc.

PLX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEF 14A Jul 1, 2016 DEF 14A
PRE 14A Jun 16, 2016 PRE 14A
8-K Jun 7, 2016 FORM 8-K
8-K Jun 6, 2016 CURRENT REPORT
10-Q May 9, 2016 10-Q
8-K May 9, 2016 FORM 8-K
10-K/A Apr 22, 2016 10-K/A
8-K Apr 8, 2016 FORM 8-K
SC 13G/A Apr 7, 2016 SC 13G/A
8-K Apr 1, 2016 FORM 8-K
10-K Mar 8, 2016 FORM 10-K
8-K Mar 8, 2016 FORM 8-K
8-K Mar 3, 2016 FORM 8-K
SC 13G/A Feb 12, 2016
SC 13G/A Feb 11, 2016 CONSONANCE CAPITAL MANAGEMENT LP
SC 13G/A Feb 8, 2016
8-K Jan 4, 2016 FORM 8-K
EFFECT Dec 18, 2015
CORRESP Dec 16, 2015
CT ORDER Dec 15, 2015
4 Dec 15, 2015 OWNERSHIP DOCUMENT
10-Q/A Dec 11, 2015 FORM 10-Q/A
CORRESP Nov 27, 2015
S-3/A Nov 27, 2015 S-3/A
SC 13G Nov 23, 2015
← Newer Page 18 of 38 · 935 filings Older →